Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest stories Story 20 Nov 2024 UCB Belgium: A global hub of healthcare innovation Read More Story 14 Nov 2024 Advancing rheumatology research: UCB at ACR Convergence 2024 Read More Story 25 Oct 2024 Moms Really Can Do It All - Meet Tracy: a Mom, Caregiver, Neuroscientist, and Advocate in the Rare... Read More Latest press releases The press releases are intended for media and financial analysts Press release 20 Nov 2024 UCB receives U.S. FDA approval for BIMZELX[®] (bimekizumab-bkzx) as the first IL-17A and IL-17F... Read More Press release 19 Nov 2024 Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant... Read More Press release 18 Nov 2024 Transparency notification BlackRock, Inc. Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Story 25 Oct 2024 Moms Really Can Do It All - Meet Tracy: a Mom, Caregiver, Neuroscientist, and Advocate in the Rare... Read More
Press release 20 Nov 2024 UCB receives U.S. FDA approval for BIMZELX[®] (bimekizumab-bkzx) as the first IL-17A and IL-17F... Read More
Press release 19 Nov 2024 Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant... Read More
